SciELO - Scientific Electronic Library Online

vol.46 número2Surgical management of achalasia in Zaria, Northern NigeriaFistuloclysis - a valuable option for a difficult problem índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados



Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Em processo de indexaçãoSimilares em Google


South African Journal of Surgery

versão On-line ISSN 2078-5151
versão impressa ISSN 0038-2361

S. Afr. j. surg. vol.46 no.2 Cape Town Mai. 2008




Surgical management of BCG vaccine-induced regional axillary lymphadenitis in HIV-infected children



J. T. JuziI; D. SidlerII; S. W. MooreIII

IM.D.; Division of paediatric Surgery, Department of Surgical Sciences, Stellenbosch University and Tygerberg Hospital, W Cape
IIM.D., F.C.S. (S.A.), M. PHIL.; Division of paediatric Surgery, Department of Surgical Sciences, Stellenbosch University and Tygerberg Hospital, W Cape
M.B. CH.B., F.R.C.S., M.D.; Division of paediatric Surgery, Department of Surgical Sciences, Stellenbosch University and Tygerberg Hospital, W Cape




There are as yet no clear surgical guidelines for the management of BCG vaccine-induced regional axillary lymphadenopathy.
OBJECTIVES: The aim of this study was to evaluate the management of the condition and to suggest possible management strategies.
A retrospective study was undertaken of 23 cases of suspected ipsilateral BCG adenitis following neo-natal BCG inoculation (2001 - 2004). Diagnosis of a BCG infection was confirmed by culture and/or gastric washout. The age of the patient and mode of presentation, imaging findings, and results of tuberculin skin testing (Mantoux test) were documented. Because of a change in management policy the first group of patients treated by primary surgery were compared with those treated by fine-needle aspiration (FNA). The influence of HIV status on outcome was assessed. Surgical complications and outcome were analysed.
Twenty-three children under 13 years of age (mean age 8.8 months, male/female ratio 1.9:1) were evaluated. Eighteen patients tested positive for HIV and 5 were HIV-negative. A positive culture for BCG bacillus was identified in 19 cases (83%) - by FNA (N=13, 68%), on pus swab (N=3, 16%), at surgery (N=1, 5%), and by gastric washing (N=2, 11%). Three HIV-negative children had granulomas on histological examination without a positive culture.
Forty-five per cent of the 11 patients treated early in the study period by primary surgery (drainage/biopsy) had complications, which included a difficult anaesthetic induction and technical surgical difficulties. The postoperative incidence of wound dehiscence/infection was extremely high in this group and 18.2% developed postoperative cutaneous sinuses. Following a change in management policy, the following 12 patients, with a comparable HIV incidence, treated by initial conservative management, had a much lower incidence of post-procedural complications.
This study confirms a high perioperative complication rate associated with the primary surgical treatment of BCG lymphadenitis in both HIV-positive and negative patients. primary surgical treatment (incisional drainage or biopsy) is therefore not considered an ideal form of management in BCG lymphadenitis because of the high fistulisation and poor wound healing, especially in the HIV-positive patient. It should be avoided as the initial approach, with needle aspiration being preferred. Surgery should therefore be confined to the unusual event of real doubt about the underlying diagnosis and the treatment of suppurative complications.



“Full text available only in PDF format”




1. Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol 1993; 88: 989-997.         [ Links ]

2. Johnson CAC, Hill ID, Bowie MD. Abdominal tuberculosis in children. S Afr Med J 1987; 72: 20-22.         [ Links ]

3. Fourie PB. BCG vaccination and the EPI. S Afr Med J 1987; 72: 323-326.         [ Links ]

4. Kabra SK, Lodha R, Seth V. Some current concepts on childhood tuberculosis. Indian J Med Res 2004; 120: 387-397.         [ Links ]

5. Schaaf HS, Beyers N, Gie RP, et al. Respiratory tuberculosis in childhood: the diagnostic value of clinical features and special investigations. Pediatr Infect Dis J 1995; 14: 189-194.         [ Links ]

6. Hesseling AC, Schaaf HS, Victor T, et al. Resistant Mycobacterium bovis Bacillus Calmette-Guerin disease: implications for management of Bacillus Calmette-Guerin disease in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004; 23: 476-479.         [ Links ]

7. Hesseling AC, Marais BJ, Gie RP, et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 2007; 25: 14-18.         [ Links ]

8. Daoud W. Control of an outbreak of BCG complications in Gaza. Respirology 2003; 8: 376-378.         [ Links ]

9. Deeks SL, Clark M, Scheifele DW, et al. Serious adverse events associated with bacille Calmette-Guerin vaccine in Canada. Pediatr Infect Dis J 2005; 24: 538-541.         [ Links ]

10. Tastan Y, Arvas A, Demlr G, Alikasifoglu M, Gur E, Kiray E. Influence of Bacillus Calmette-Guerin vaccination at birth and 2 months of age on the peripheral blood T-cell subpopulations (gamma/delta and alpha-beta T cell). Pediatr Allergy Immunol 2005; 16: 624-629.         [ Links ]

11. Kumar R, Dwivedi A, Kumar P, Kohli N. Tuberculous meningitis in BCG vaccinated and unvaccinated children. J Neurol Neuro-surg Psychiatry 2006; 76: 1550-1554.         [ Links ]

12. Baki A, Oncu M, Usta S, Yildiz K, Karaguzel A. Therapy of regional lymphadenitis following BCG vaccination. Infection 1991; 19: 414-416.         [ Links ]

13. Caglayan S, Yegin O, Kayran K, Timocin N, Kasirga E, Gun M. Is medical therapy effective for regional lymphadenitis following BCG vaccination? Am J Dis Child 1987; 141: 1213-1214.         [ Links ]

14. Kuyucu N, Kuyucu S, Ocal B, Tezic T. Comparison of oral erythromycin, local administration of streptomycin and placebo therapy for non-suppurative Bacillus Cal-mette-Guerin lymphadenitis. Pediatr Infect Dis J 1998; 17: 524-525.         [ Links ]

15. Noah PK, Pande D, Johnson B, Ashley D. Evaluation of oral erythromycin and local isoniazid instillation therapy in infants with Bacillus Calmette-Guerin lymphadenitis and abscesses. Pediatr Infect Dis J 1993; 12: 136-139.         [ Links ]

16. Close GC, Nasiiro R. Management of BCG adenitis in infancy. J Trop Pediatr 1985; 31: 286.         [ Links ]

17. Banani SA, Alborzi A. Needle aspiration for suppurative post-BCG adenitis. Arch Dis Child 1994; 71: 446-447.         [ Links ]

18. Hengster P, Sölder B, Fille M, et al. Surgical treatment of Bacillus Calmette-Guerin lymphadenitis. World J Surg 1997; 21: 520-523.         [ Links ]

19. Cagalayn S, Afrikan A, Yaprak I, Aksoz K, Kansoy S. Management of suppuration in regional lymphnodes secondary to BCG vaccination. Acta Paediatr Jpn 1991; 33: 699-702.         [ Links ]

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons